Artemis Program

GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial

system
By system
July 14, 2026 • 75 views
Original source: Biztoc.com
GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial

GSK's bet on Hansoh Pharmaceutical's antibody-drug conjugate (ADC) seems to be paying off as the drug met all its endpoints in a Phase III trial in China. In the pivotal ARTEMIS-008 trial (NCT06498479), risvutatug rezetecan (Ris-Rez) met its primary endpoint …

system
system

Article Author

Related Articles
LatConnect 60 Expands India Market Presence for SWIRSAT With NSIL Agreement and GeoSyze Partnership
1 hour ago
APOD: 2026 September 11 – M83: The Southern Pinwheel
1 hour ago
eROSITA's Second Data Release Catalog Delivering the Most Comprehensive High-Energy Census of the Cosmos to Date
7 hours ago
NASA Invites Media to Djibouti Artemis Accords Signing Ceremony
9 hours ago
Topic Tags
Nasa Artemis Ii Lunar Mission Space Launch System Artemis Iii Orion Spacecraft Blue Origin Spacex Artemis Program Reid Wiseman Deep Space New Glenn Commercial Launch Low Earth Orbit Orion Tiangong Chinese National Space Administration Crewed Spaceflight Pbs Documentary Moon Exploration Ng 3 Rocket Reusability Be 4 Cape Canaveral Vulcan Centaur United Launch Alliance Space Force Solid Rocket Boosters National Security Space Launch Gem 63xlmotor
Stay Updated

Subscribe to our newsletter for the latest news